Medesis Pharma SA (ALMDP.PA) Forecast, Price Target & Analyst Ratings

EPA:ALMDP • FR0010844464

Current stock price

0.35 EUR
-0.03 (-8.14%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Medesis Pharma SA (ALMDP.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€0.82
+ 133.14% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
40.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€0.82
Upside
+ 133.14%
From current price of €0.35 to mean target of €0.82, Based on 7 analyst forecasts
Low
€0.81
Median
€0.82
High
€0.84

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for ALMDP.PA. The average price target is 0.82 EUR. This implies a price increase of 133.14% is expected in the next year compared to the current price of 0.35.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALMDP Current Analyst RatingALMDP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

ALMDP Historical Analyst RatingsALMDP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
40.00%
ALMDP.PA was analyzed by 7 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ALMDP.PA.
In the previous month the buy percentage consensus was at a similar level.
ALMDP.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
ALMDP.PA revenue by date.ALMDP.PA revenue by date.
200K
1,900.00%		200K73.1K
-63.45%
-100.00%		10.3M
-100.00%
EBITDA
YoY % growth
ALMDP.PA ebitda by date.ALMDP.PA ebitda by date.
N/AN/AN/A-6.18M
-100.00%		-3.09M
50.00%		15.45M
600.00%		-5.15M
-133.33%		-5.15M
EBIT
YoY % growth
ALMDP.PA ebit by date.ALMDP.PA ebit by date.
-789K
34.30%		-987.9K
-25.21%		-3.215M
-225.42%		-6.18M
-92.24%		-3.09M
50.00%		-1.236M
60.00%		8.446M
783.33%		-2.163M
-125.61%
Operating Margin
ALMDP.PA operating margin by date.ALMDP.PA operating margin by date.
-394.50%-493.95%-4,397.81%N/AN/AN/A82.00%N/A
EPS
YoY % growth
ALMDP.PA eps by date.ALMDP.PA eps by date.
N/AN/AN/A-1.48
-80.00%		-0.69
53.47%		-0.26
62.69%		1.91
840.00%		-0.43
-122.70%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALMDP.PA Yearly Revenue VS EstimatesALMDP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2025 2M 4M 6M 8M 10M
ALMDP.PA Yearly EPS VS EstimatesALMDP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 1 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Medesis Pharma SA / ALMDP.PA Forecast FAQ

What do analysts expect the price target to be for Medesis Pharma SA (ALMDP.PA)?

7 analysts have analysed ALMDP.PA and the average price target is 0.82 EUR. This implies a price increase of 133.14% is expected in the next year compared to the current price of 0.35.